Maxim Group Maintains Avenue Therapeutics(ATXI.US) With Buy Rating

Futu NewsNov 17 00:31 · Ratings

Maxim Group Remains a Buy on Avenue Therapeutics (ATXI)

TipRanksNov 16 23:35

Avenue Therapeutics Q3 EPS $(1.92) Misses $(0.94) Estimate

BenzingaNov 15 06:49

Avenue Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:24 · Announcements

Avenue Therapeutics | 8-K: Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

SECNov 15 05:16

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

GlobeNewswireOct 9 20:30